Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chapel Hill, North Carolina 27514


Purpose: The purpose of this protocol is to understand how individuals respond to the air pollutant ozone at elevated temperatures. Ultimately, this will help us understand what the risks from poor air quality are during a heat wave. Participants: We will recruit up to 30 healthy adults, 18-55 years old, to participate in this study. Procedures (methods): Subjects will be exposed to clean air and to 0.3 ppm of ozone for 2 hours with intermittent exercise in a controlled environment chamber. For each exposure the temperature in the chamber will be between 31-34oC (88-93 oF). Because the aim of the study is to mimic high exposure during a heat wave, we will perform exposures only on days when mean ambient temperatures was less than 24 oC in Chapel Hill on the previous day. Primary endpoints will include spirometry and Heart Rate Variability monitoring. Secondary endpoints will include analysis of blood clotting/coagulation factors, and analysis of soluble factors present in plasma.

Study summary:

Over the past decades, air quality in the U.S. has improved significantly. Even so, millions of people in the U.S. still live in counties that do not meet air quality standards for one or more pollutants. Global climate change is widely accepted to be occurring and is thought to have a range of major and potentially adverse effects on the ecosystem. Additionally, changes in the climate can lead to higher concentrations of harmful air pollutants, and the presence of some air pollutants in the atmosphere can also accelerate climate change. Health effects are impacted by complex interactions between climate change and air quality. Research is needed to identify the public health consequences of these interactions. One aspect that has been understudied is how physiological responses to elevated temperature are impacted by the additional stressor of air pollution. Several epidemiological studies have shown a strong link between exposure to air pollution and adverse cardiopulmonary effects, such as respiratory tract infections, exacerbation of asthma, chronic bronchitis, ischemic heart disease, and stroke [1-3]. Ozone is a major component of photochemical smog. Controlled human exposure studies have been critical in demonstrating that it can cause decrements in lung function [4-10] and lung inflammation.[11-13] The inflammation includes increased neutrophils and soluble pro-inflammatory mediators in the lower airways [14, 15]. The majority of these studies involved controlled exposures to relatively high (0.1 - 0.4ppm) concentrations for short periods of time (typically 2 hours). These short-term exposure studies are useful because a) they provide the strongest and most quantifiable exposure-response data and b) they allow the investigation of biological changes that in themselves are transient and inconsequential but can be extrapolated to predict health outcomes in susceptible populations or in long-term exposures. For example, healthy individuals exposed to 0.4ppm ozone exposure for 2hr [16] showed a13.5 % decrement in FEV1, often accompanied by only mild symptoms such as tracheobronchial irritation and cough. However, by 3hours after exposure, these symptoms had largely disappeared and only a 2.7% FEV1 decrement was detectable. By 24hrs, even at higher ozone concentrations the recovery phase has normally completed. The primary public health concern is in individuals with respiratory disease. If these same changes occurred in a person with reduced reserve, the ozone-induced changes would be superimposed on preexisting pulmonary impairment and may have significant health effects. Despite almost 30 years of research into the effects of ozone, there are very few studies of the interaction between ozone and temperature. Although ozone is normally elevated when the weather is dry and hot, most controlled chamber studies are performed at moderate temperatures (70-75 oF). Those studies that addressed higher temperatures were generally performed in the run-up to the Los Angeles Olympics in 1984 and centered on impairment of exercise performance. For example, Gibbons and Adams studied ten aerobically trained young adult females exercised continuously at 66% of maximum O2 uptake for 1 h while exposed orally to filtered air and 0.15 and 0.30 ppm ozone in both moderate (24 degrees oC) and hot (35 degrees oC) ambient conditions and showed that subjects were more likely to cease exercising prematurely at hot temperatures.[17] Gong studied elite cyclists and showed similar results.[18] Folinsbee et al., studied the effects of a 2-h exposure to high level ozone (0.5 ppm) in 14 nonsmoking males under four environmental conditions (64.4, 80.0, 85.2, and 92.0 oF) and found that the greatest decrease in FVC occurred when ozone exposures were at the highest temperature.[19] Those cited studies have focused on respiratory outcomes. Yet it is becoming clear that ozone may have systemic and cardiac effects. Ozone reacts rapidly with respiratory tissues and is not absorbed or transported to extrapulmonary sites. However, recent studies have also shown associations between long-term ozone exposure and cardiovascular morbidity [20, 21]. In addition, short-term exposures to ozone may cause minor transient changes in high frequency heart rate variability (HRV) in healthy adults [22]. Experimental studies have shown that heat stress can have a similar modest effect on this component of HRV. [23] The effect of the combination has not been studied to date. Epidemiology studies assessing the ozone-temperature-cardiac relationship have generally been uninformative since high ozone days normally occur during hot weather. Traditional methods are not suitable to discriminate between the effects of ozone and temperature, let alone their interaction. Those that have studied the relationship have shown a negative association between temperature and ozone-mortality due to increased use in air conditioning. [24] A very recent study, however, using novel approaches examined whether ozone modified the associations between temperature and cardiovascular mortality in 95 large communities in the USA, 1987-2000, in summer. They found that a 10oC increase in temperature on the same day was associated with an increase in mortality by 1.17% and 8.31% for the lowest and highest level of ozone concentrations in all communities, respectively.[25] The purpose of this study is to perform the first controlled chamber study in order to understand the cardiovascular changes resulting from the interaction between heat and ozone. The information obtained from this study will enable the EPA to evaluate better the risks from air pollutants during a heat wave and provide advice on activities to mitigate the effects.


Inclusion Criteria: - 1. Pass a physical exam performed by study physicians during the screening visit under a separate protocol. 2. Normal lung function: 1. FVC > 75 % of that predicted for gender, ethnicity, age and height. 2. FEV1 > 75 % of that predicted for gender, ethnicity, age and height. 3. FEV1/FVC ratio > 75 % of predicted values. 3. Oxygen saturation of > 96 %. 4. Ability to tolerate intervals of moderate exercise. Exclusion Criteria: - 1. A history of chronic illnesses such as diabetes, rheumatological diseases, immunodeficiency state, known clinically significant cardiac disease (including myocardial infarction, congestive heart failure and angina), chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma and lung cancer. 2. If the subject is pregnant, attempting to become pregnant or breastfeeding. 3. Subjects currently taking medications which may impact the results of the ozone challenge or interfere with any other medications potentially used in the study (to include systemic steroids and beta blockers). Subjects must refrain from all over the counter anti-inflammatory agents, and anti-oxidants for a period of one week prior to exposure. Medications not specifically mentioned here may be reviewed by the investigators prior to a subject's inclusion in the study. 4. Smoking history within 2 years of the study. 5. Untreated hypertension (≥ 150 systolic, ≥ 90 diastolic). 6. Skin diseases or sensitivity precluding the use of ECG electrodes. 7. Symptom score greater than 21 (out of a possible 40-see accompanying score sheet) for total symptom score. Only one score may be equal to 3. 8. Dementia. 9. Unspecified illness or condition which in the judgment of the investigator might increase the risk associated with inhalation challenge or exercise. 10. Subjects who do not understand or speak English. 11. Subjects who are unable to perform moderate exercise.



Primary Contact:

Principal Investigator
David Diaz-Sanchez, PhD
U.S. Environmental Protection Agency

Backup Contact:


Location Contact:

Chapel Hill, North Carolina 27514
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.